Cargando…
Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
Autores principales: | Rudnicka, Lidia, Rakowska, Adriana, Waskiel-Burnat, Anna, Kurzeja, Marta, Olszewska, Malgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149466/ https://www.ncbi.nlm.nih.gov/pubmed/34051315 http://dx.doi.org/10.1016/j.jaad.2021.05.020 |
Ejemplares similares
-
Lipocalin-2 and insulin as new biomarkers of alopecia areata
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2022) -
Adiponectin as a novel biomarker of disease severity in alopecia areata
por: Stochmal, Anna, et al.
Publicado: (2021) -
Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2023) -
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023) -
The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)